Found: 14
Select item for more details and to access through your institution.
A Rare Case of Triple-Negative Essential Thrombocythemia in a Young Postsplenectomy Patient: A Diagnostic Challenge.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
SMART STOP: A PHASE II CLINICAL TRIAL OF LENALIDOMIDE, TAFASITAMAB, RITUXIMAB, AND ACALABRUTINIB ALONE AND WITH RESPONSE ADAPTED CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED DLBCL.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 837, doi. 10.1002/hon.3166_OT17
- By:
- Publication type:
- Article
Brentuximab Vedotin‐Nivolumab alone and then with Rituximab‐Cyclophosphamide‐Doxorubicin‐Prednisone as Frontline Therapy of Primary Mediastinal Large B‐cell Lymphoma.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 167, doi. 10.1002/hon.3163_T03
- By:
- Publication type:
- Article
PHASE 1B/2A STUDY OF AZD4573 (CDK9I) AND ACALABRUTINIB IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (R/R DLBCL).
- Published in:
- Hematological Oncology, 2023, v. 41, p. 129, doi. 10.1002/hon.3163_87
- By:
- Publication type:
- Article
A Phase II Investigator Initiated Study of Acalabrutinib, Lenalidomide and Rituximab (aR2) in Patients with Previously Untreated High Tumor Burden Follicular Lymphoma.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 383, doi. 10.1002/hon.3164_277
- By:
- Publication type:
- Article
CARDIOVASCULAR EVENTS AMONG ADULT PATIENTS WITH AGGRESSIVE B‐CELL LYMPHOMA TREATED WITH STANDARD OF CARE AXICABTAGENE CILOLEUCEL AND TISAGENLECLEUCEL.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.177_2880
- By:
- Publication type:
- Article
PROGNOSTIC VALUE OF PRE‐TREATMENT PET SCAN IN PATIENTS WITH FOLLICULAR LYMPHOMA RECEIVING FRONTLINE THERAPY.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 53, doi. 10.1002/hon.22_2629
- By:
- Publication type:
- Article
RELAPSED AND REFRACTORY NODULAR LYMPHOCYTE‐PREDOMINANT HODGKIN LYMPHOMA (NLPHL): A US ANALYSIS FROM MD ANDERSON CANCER CENTER.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 500, doi. 10.1002/hon.182_2631
- By:
- Publication type:
- Article
DIFFUSE LARGE B CELL LYMPHOMA WITH SECONDARY CENTRAL NERVOUS SYSTEM INVOLVEMENT: CAN MRI PATTERN HELP PREDICTING OUTCOME?
- Published in:
- Hematological Oncology, 2019, v. 37, p. 442, doi. 10.1002/hon.118_2631
- By:
- Publication type:
- Article
CLINICAL IMPLICATIONS OF CYTOPENIAS BEYOND DAY 30 AFTER AXI‐CEL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 311, doi. 10.1002/hon.120_2630
- By:
- Publication type:
- Article
PROGNOSTIC VALUE OF PRE‐TREATMENT PET SCAN IN PATIENTS WITH FOLLICULAR LYMPHOMA RECEIVING FRONTLINE THERAPY.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 53, doi. 10.1002/hon.22_2629
- By:
- Publication type:
- Article
RELAPSED AND REFRACTORY NODULAR LYMPHOCYTE‐PREDOMINANT HODGKIN LYMPHOMA (NLPHL): A US ANALYSIS FROM MD ANDERSON CANCER CENTER.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 500, doi. 10.1002/hon.182_2631
- By:
- Publication type:
- Article
CLINICAL IMPLICATIONS OF CYTOPENIAS BEYOND DAY 30 AFTER AXI‐CEL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 311, doi. 10.1002/hon.120_2630
- By:
- Publication type:
- Article
DIFFUSE LARGE B CELL LYMPHOMA WITH SECONDARY CENTRAL NERVOUS SYSTEM INVOLVEMENT: CAN MRI PATTERN HELP PREDICTING OUTCOME?
- Published in:
- Hematological Oncology, 2019, v. 37, p. 442, doi. 10.1002/hon.118_2631
- By:
- Publication type:
- Article